Takeda/Mersana Deal Adds To ADC Pipeline
Mersana Therapeutics is getting a vote of confidence from long-time partner Takeda as the two companies expand their collaboration in antibody-drug conjugates and plan to move a molecule into the clinic.
Mersana Therapeutics is getting a vote of confidence from long-time partner Takeda as the two companies expand their collaboration in antibody-drug conjugates and plan to move a molecule into the clinic.